[HTML][HTML] Oral mucosa immunity: ultimate strategy to stop spreading of pandemic viruses

H Jang, M Matsuoka, M Freire - Frontiers in Immunology, 2023 - frontiersin.org
Global pandemics are most likely initiated via zoonotic transmission to humans in which
respiratory viruses infect airways with relevance to mucosal systems. Out of the known …

[HTML][HTML] Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections

KJ Selva, P Ramanathan, ER Haycroft, A Reynaldi… - JCI insight, 2023 - ncbi.nlm.nih.gov
Understanding mucosal antibody responses from SARS-CoV-2 infection and/or vaccination
is crucial to develop strategies for longer term immunity, especially against emerging viral …

[HTML][HTML] Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders

J Denis, A Garnier, L Cheutin, A Ferrier… - Frontiers in …, 2023 - frontiersin.org
Introduction Current approved COVID-19 vaccines, notably mRNA and adenoviral vectored
technologies, still fail to fully protect against infection and transmission of various SARS-CoV …

Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses

D Sinha, M Yaugel-Novoa, L Waeckel, S Paul… - Antiviral Research, 2024 - Elsevier
Mucosal immunity has regained its spotlight amidst the ongoing Coronavirus Disease 19
(COVID-19) pandemic, with numerous studies highlighting the crucial role of mucosal …

[HTML][HTML] Salivary IgA and vimentin differentiate in vitro SARS-CoV-2 infection: A study of 290 convalescent COVID-19 patients

S Ellis, R Way, M Nel, A Burleigh, I Doykov… - Mucosal …, 2024 - Elsevier
SARS-CoV-2 initially infects cells in the nasopharynx and oral cavity. The immune system at
these mucosal sites plays a crucial role in minimizing viral transmission and infection. To …

[HTML][HTML] SARS-CoV-2-Specific Immune Responses in Vaccination and Infection during the Pandemic in 2020–2022

W Inoue, Y Kimura, S Okamoto, T Nogimori… - Viruses, 2024 - mdpi.com
To gain insight into how immunity develops against SARS-CoV-2 from 2020 to 2022, we
analyzed the immune response of a small group of university staff and students who were …

[PDF][PDF] Persistent immune and clotting dysfunction detected in saliva and blood plasma after COVID-19

H Jang, S Choudhury, Y Yu, BL Sievers, T Gelbart… - Heliyon, 2023 - cell.com
A growing number of studies indicate that coronavirus disease 2019 (COVID-19) is
associated with inflammatory sequelae, but molecular signatures governing the normal …

Subclinical SARS-CoV-2 Infections and Endemic Human Coronavirus Immunity Shape SARS-CoV-2 Saliva Antibody Responses

TL Conner, E Goguet, H Haines-Hull, A Segard… - medRxiv, 2024 - medrxiv.org
This study characterized antibody responses induced by COVID-19 mRNA vaccination and
SARS-CoV-2 infection in saliva. Utilizing multiplex microsphere-based immunoassays, we …

[HTML][HTML] 基于黏膜sIgA 抗体的非洲猪瘟病毒感染早期血清学检测方法的建立

白昀, 谢青云, 欧阳伟, 甘源, 袁厅, 赵东明, 步志高… - 畜牧兽医学报, 2024 - xml-data.org
目前的非洲猪瘟病毒(ASFV) 血清学检测方法存在因采血引起交叉感染风险,
抗体转阳滞后影响检测敏感性等问题, 因此建立一种无创采样且可实现早期诊断的血清学方法 …

Dynamics of anti-influenza mucosal IgA over a season in a cohort of individuals living or working in a long-term care facility

MDT Hitchings, BA Borgert, A Shir… - The Journal of …, 2023 - academic.oup.com
Background Serological surveys are used to ascertain influenza infection and immunity, but
evidence for the utility of mucosal immunoglobulin A (IgA) as a correlate of infection or …